22 Nw, LP Catalyst Biosciences, Inc. Transaction History

22 Nw, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $1.3 Million - $5.95 Million	-1,429,242 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $2.68 Million - $3.49 Million	653,968 Added 84.35%	1,429,242 $6.19 Million
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $14,592 - $21,164	2,960 Added 0.38%	775,274 $3.91 Million
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $153,916 - $220,296	36,473 Added 4.96%	772,314 $3.32 Million
Q3 2019 Nov 14, 2019	BUY	$4.91 - $9.31 $2.26 Million - $4.29 Million	460,905 Added 167.64%	735,841 $3.61 Million
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $937,993 - $1.4 Million	132,485 Added 93.0%	274,936 $2.03 Million
Q4 2018 Feb 08, 2019	BUY	$6.59 - $11.28 $938,752 - $1.61 Million	142,451 New	142,451 $1.12 Million

230

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

Stay updated on 22 Nw, LP with notifications on news.